Skip to main content

Gentag, MacroArray to Collaborate on Wireless Prostate Cancer Assay

NEW YORK (GenomeWeb News) – Privately held firms Gentag and MacroArray Technologies said today that they will collaborate on developing a wireless immunoassay for prostate cancer.
 
The new test would combine Gentag’s cell-phone sensor technology with MacroArray’s proteomics discovery technology to create a disposable, wireless diagnostic test.
 
Gentag said the test would work similarly to currently available pregnancy strip tests, with men placing a urine sample on a test strip that incorporates an imbedded wireless tag. Antibodies on the strip would react with the sample and resulting data would be sent to an attending physician.
 
The firms plan to develop additional diagnostic tests based on their combined technologies, but the prostate cancer test is first in the pipeline.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.